{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:34:20Z","timestamp":1794087260795,"version":"4.8.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/md.0000000000001809","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T10:39:52Z","timestamp":1446115192000},"page":"e1809","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and Safety of Topiramate for Essential Tremor"],"prefix":"10.1097","volume":"94","author":[{"given":"Kuo-Hsuan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20210226","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMcp010928","article-title":"Clinical practice. Essential tremor.","volume":"345","author":"Louis","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-32-20210226","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.25.3.259","article-title":"The effect of alcohol on essential tremor.","volume":"25","author":"Growdon","year":"1975","journal-title":"Neurology"},{"key":"R3-32-20210226","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1176\/ajp.139.11.1471","article-title":"High alcoholism rate in patients with essential tremor.","volume":"139","author":"Schroeder","year":"1982","journal-title":"Am J Psychiatry"},{"key":"R4-32-20210226","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1592\/phco.23.10.1105.32750","article-title":"Essential tremor: diagnosis and treatment.","volume":"23","author":"Chen","year":"2003","journal-title":"Pharmacotherapy"},{"key":"R5-32-20210226","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00002018-200326070-00003","article-title":"Benefits and risks of pharmacological treatments for essential tremor.","volume":"26","author":"Lyons","year":"2003","journal-title":"Drug Saf"},{"key":"R6-32-20210226","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.parkreldis.2010.07.011","article-title":"Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists.","volume":"16","author":"Diaz","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"R7-32-20210226","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jnnp.48.9.911","article-title":"Primidone in essential tremor of the hands and head: a double blind controlled clinical study.","volume":"48","author":"Findley","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-32-20210226","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor.","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"issue":"Suppl 8","key":"R10-32-20210226","first-page":"5","article-title":"Mechanism of action of newer anticonvulsants.","volume":"64","author":"White","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"R11-32-20210226","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1111\/j.1528-1157.2000.tb02175.x","article-title":"Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults.","volume":"41","author":"Reife","year":"2000","journal-title":"Epilepsia"},{"key":"R12-32-20210226","first-page":"CD010610","article-title":"Topiramate for the prophylaxis of episodic migraine in adults.","volume":"6","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-32-20210226","first-page":"1","article-title":"Prospective double blind study of the use of topiramato vs. placebo in the treatment of essential tremor.","volume":"44","author":"Carrasco Vargas","year":"2011","journal-title":"Neurol Neurocir Psiquiatr"},{"key":"R14-32-20210226","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: a double-blind, placebo-controlled trial.","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"key":"R15-32-20210226","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002826-200603000-00007","article-title":"A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor.","volume":"29","author":"Frima","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"R16-32-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0b013e3180d09969","article-title":"Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.","volume":"31","author":"Connor","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"R17-32-20210226","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","article-title":"Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"77","author":"Zesiewicz","year":"2011","journal-title":"Neurology"},{"issue":"Suppl 1","key":"R18-32-20210226","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1526-4610.2005.4501005.x","article-title":"Topiramate in migraine prevention.","volume":"45","author":"Silberstein","year":"2005","journal-title":"Headache"},{"key":"R21-32-20210226","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.59.1.132","article-title":"A double-blind placebo-controlled trial of topiramate treatment for essential tremor.","volume":"59","author":"Connor","year":"2002","journal-title":"Neurology"},{"issue":"Suppl 5","key":"R22-32-20210226","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1999.tb00913.x","article-title":"Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.","volume":"40","author":"White","year":"1999","journal-title":"Epilepsia"},{"key":"R23-32-20210226","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200523625","article-title":"Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice.","volume":"115","author":"Kralic","year":"2005","journal-title":"J Clin Invest"},{"key":"R24-32-20210226","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0006-8993(95)01214-1","article-title":"Effects of CO2 on excitatory transmission apparently caused by changes in intracellular pH in the rat hippocampal slice.","volume":"706","author":"Lee","year":"1996","journal-title":"Brain Res"},{"key":"R25-32-20210226","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00171-X","article-title":"Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance.","volume":"42","author":"Herrero","year":"2002","journal-title":"Neuropharmacology"},{"key":"R26-32-20210226","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1046\/j.1528-1157.2001.41700.x","article-title":"Postmarketing experience with topiramate and cognition.","volume":"42","author":"Tatum WOt, French","year":"2001","journal-title":"Epilepsia"},{"key":"R27-32-20210226","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.51.2.627","article-title":"Topiramate increases cerebral GABA in healthy humans.","volume":"51","author":"Kuzniecky","year":"1998","journal-title":"Neurology"},{"key":"R28-32-20210226","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.58.3.368","article-title":"Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults.","volume":"58","author":"Kuzniecky","year":"2002","journal-title":"Neurology"},{"key":"R29-32-20210226","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yebeh.2007.02.007","article-title":"The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.","volume":"10","author":"Gomer","year":"2007","journal-title":"Epilepsy Behav"},{"key":"R30-32-20210226","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.yebeh.2006.05.004","article-title":"Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.","volume":"9","author":"Jansen","year":"2006","journal-title":"Epilepsy Behav"},{"key":"R31-32-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-1211(03)00078-0","article-title":"Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients.","volume":"54","author":"Kockelmann","year":"2003","journal-title":"Epilepsy Res"},{"key":"R32-32-20210226","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","article-title":"Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.","volume":"61","author":"McElroy","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R33-32-20210226","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-8993(93)90458-Y","article-title":"Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats.","volume":"613","author":"Stanley","year":"1993","journal-title":"Brain Res"},{"key":"R34-32-20210226","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.2007.136929","article-title":"Topiramate, nutrition and weight change: a prospective study.","volume":"79","author":"Klein","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R35-32-20210226","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.seizure.2003.12.001","article-title":"Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients-a retrospective analysis.","volume":"13","author":"Reiter","year":"2004","journal-title":"Seizure"},{"key":"R36-32-20210226","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.disamonth.2013.12.001","article-title":"Neuropathic pain: etiology, pathophysiology, mechanisms, and evaluations.","volume":"60","author":"Jay","year":"2014","journal-title":"Dis Mon"},{"key":"R37-32-20210226","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/OPTH.S27695","article-title":"Topiramate and the vision: a systematic review.","volume":"6","author":"Abtahi","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R38-32-20210226","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/head.12480","article-title":"The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.","volume":"55","author":"Jion","year":"2015","journal-title":"Headache"},{"key":"R39-32-20210226","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/01.WNL.0000056637.37509.C6","article-title":"Topiramate and word-finding difficulties in patients with epilepsy.","volume":"60","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"R40-32-20210226","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1526-4610.2007.00860.x","article-title":"Language disturbances as a side effect of prophylactic treatment of migraine.","volume":"48","author":"Coppola","year":"2008","journal-title":"Headache"},{"issue":"Suppl 2","key":"R41-32-20210226","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1528-1157.1996.tb06029.x","article-title":"Safety of topiramate: adverse events and relationships to dosing.","volume":"37","author":"Shorvon","year":"1996","journal-title":"Epilepsia"},{"key":"R42-32-20210226","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00240-010-0347-5","article-title":"Nephrolithiasis in topiramate users.","volume":"39","author":"Maalouf","year":"2011","journal-title":"Urol Res"},{"key":"R43-32-20210226","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/bcp.12283","article-title":"Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review.","volume":"77","author":"DellOrto","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R44-32-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.urology.2010.06.048","article-title":"Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate.","volume":"77","author":"Kaplon","year":"2011","journal-title":"Urology"},{"key":"R45-32-20210226","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s004670050354","article-title":"Renal tubular acidosis and osteopetrosis with carbonic anhydrase II deficiency: pathogenesis of impaired acidification.","volume":"11","author":"Nagai","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"R46-32-20210226","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.ajkd.2006.07.003","article-title":"Biochemical and stone-risk profiles with topiramate treatment.","volume":"48","author":"Welch","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R47-32-20210226","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1006\/ebeh.2001.0285","article-title":"Language disturbances as side effects of topiramate and zonisamide therapy.","volume":"2","author":"Ojemann","year":"2001","journal-title":"Epilepsy Behav"},{"key":"R48-32-20210226","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T03:15:27Z","timestamp":1718162127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201510270-00032"}},"subtitle":["A Meta-Analysis of Randomized Controlled Trials"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":45,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001809","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}